Snowden Capital Advisors LLC Bio Rad Laboratories, Inc. Transaction History

Snowden Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $54,249 - $69,867	-117 Reduced 18.87%	503 $248,000
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $127,470 - $178,707	243 Added 64.46%	620 $349,000
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $267,232 - $299,594	377 New	377 $284,000
Q3 2021 Feb 05, 2024	BUY	$657.71 - $825.77 $357,136 - $448,393	543 New	543 $405 Million
Q2 2021 Jan 08, 2024	BUY	$576.64 - $649.04 $313,115 - $352,428	543 New	543 $350 Million
Q3 2019 Jan 08, 2024	SELL	$304.55 - $345.24 $7.61 Million - $8.63 Million	-25,000 Closed	0 $0
Q2 2019 Jan 08, 2024	BUY	$286.93 - $312.59 $7.17 Million - $7.81 Million	25,000 New	25,000 $26.9 Million

459

19.6M

23.2K

37.4K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.1B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.